1. Home
  2. SLGL vs CPBI Comparison

SLGL vs CPBI Comparison

Compare SLGL & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • CPBI
  • Stock Information
  • Founded
  • SLGL 1997
  • CPBI 2023
  • Country
  • SLGL Israel
  • CPBI United States
  • Employees
  • SLGL N/A
  • CPBI N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • CPBI
  • Sector
  • SLGL Health Care
  • CPBI
  • Exchange
  • SLGL Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • SLGL 69.1M
  • CPBI 63.0M
  • IPO Year
  • SLGL 2018
  • CPBI N/A
  • Fundamental
  • Price
  • SLGL $23.98
  • CPBI $15.60
  • Analyst Decision
  • SLGL
  • CPBI
  • Analyst Count
  • SLGL 0
  • CPBI 0
  • Target Price
  • SLGL N/A
  • CPBI N/A
  • AVG Volume (30 Days)
  • SLGL 33.1K
  • CPBI 1.8K
  • Earning Date
  • SLGL 11-14-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • SLGL N/A
  • CPBI N/A
  • EPS Growth
  • SLGL N/A
  • CPBI 0.69
  • EPS
  • SLGL N/A
  • CPBI 0.98
  • Revenue
  • SLGL $23,931,000.00
  • CPBI $19,464,000.00
  • Revenue This Year
  • SLGL N/A
  • CPBI N/A
  • Revenue Next Year
  • SLGL $31.17
  • CPBI N/A
  • P/E Ratio
  • SLGL N/A
  • CPBI $15.92
  • Revenue Growth
  • SLGL 264.86
  • CPBI 9.30
  • 52 Week Low
  • SLGL $4.01
  • CPBI $11.52
  • 52 Week High
  • SLGL $30.00
  • CPBI $16.71
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 58.56
  • CPBI 48.24
  • Support Level
  • SLGL $23.13
  • CPBI $15.75
  • Resistance Level
  • SLGL $24.85
  • CPBI $16.03
  • Average True Range (ATR)
  • SLGL 2.36
  • CPBI 0.14
  • MACD
  • SLGL -0.43
  • CPBI -0.04
  • Stochastic Oscillator
  • SLGL 39.19
  • CPBI 13.67

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.

Share on Social Networks: